Preoperative α-adrenoceptor block in asymptomatic pheochromocytoma? Pro;Präoperative α-Rezeptoren-Blockade beim asymptomatischen Phäochromozytom? Pro

Chirurg

Volumn 83, Issue 6, 2012, Pages 546-550

  Bracker, L ^a   Rath, S ^a   Dralle, H ^a   Bucher, M ^a  

^a MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

adrenoceptor block; Imaging techniques; Pheochromocytoma; Risk stratification; Subgroups

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE;

ADRENAL TUMOR; ARTICLE; ASYMPTOMATIC DISEASE; BLOOD; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; HYPERTENSION; NUCLEAR MAGNETIC RESONANCE IMAGING; PEROPERATIVE COMPLICATION; PHEOCHROMOCYTOMA; PREOPERATIVE CARE; RISK ASSESSMENT;

ADRENAL GLAND NEOPLASMS; ADRENERGIC ALPHA-ANTAGONISTS; ASYMPTOMATIC DISEASES; CATECHOLAMINES; HUMANS; HYPERTENSION; INTRAOPERATIVE COMPLICATIONS; MAGNETIC RESONANCE IMAGING; PHEOCHROMOCYTOMA; PREOPERATIVE CARE; RISK ASSESSMENT; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84862492155     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-011-2195-4     Document Type: Article

References (29)

1. Adams HA, Hempelmann G (1993) Anästhesie bei Patienten mit Phäochromozytom - Eigene Ergebnisse und Übersicht. Anästhesiol Intensivmed Notfallmed Schmerzther 28:500-509
2. Agarwal G, Sadacharan D, Kapoor A et al (2011) Cardiovascular dysfunction and catecholamine cardiomyopathy in pheochromocytoma patients and their reversal following surgical cure: results of a prospective case-control study. Surgery 150:1202-121
3. Baguet JP, Hammer L, Mazzuco TL et al (2004) Circumstances of discovery of phaeochromocytoma: a retrospective study of 41 consecutive patients. Eur J Endocrinol 150:681-686
4. Bajwa SS, Bajwa SK (2011) Implications and considerations during pheochromocytoma resection: a challenge to the anesthesiologist. Indian J Endocrinol Metab 15:337-344
5. Brauckhoff M, Gimm O, Dralle H, Lehnert H (2004) Preoperative and surgical therapy in sporadic and familial pheochromocytoma. Front Horm 31:121-144
6. Bravo E, Fouad-Tarazi F, Rossi G et al (1990) A reevaluation of the hemodynamics of pheochromocytoma. Hypertension 15:128-131
7. Bruynzeel H, Feelders RA, Groenland TH et al (2010) Risk factors for hemodynamic instability during surgery for pheochromocytoma. J Clin Endocrinol Metab 95:678-685
8. Chapman N, Chen CY, Fujita T et al (2010) Time to re-appraise the role of alpha-1 adrenoceptor antagonists in the management of hypertension J Hypertens 28:1796-1803
9. Crout JR, Sjoerdsma A (1964) Turnover and metabolism of catecholamines in patients with pheochromocytoma. J Clin Invest 43:94-102
10. Duh QY (2001) Evolving surgical management for patients with pheochromocytoma. Duh QY. Comment on J Clin Endocrinol Metab 86:1480-1486
11. Fischler L, Ensner R, Bernhardt D (1999) Präoperativ asymptomatisches Inzidentalom der linken Nebenniere. Schweiz Med Wochenschr 129:1033-1038
12. Goldstein RE, O'Neill JA Jr, Holcomb GW et al (1999) Clinical experience over 48 years with pheochromocytoma. Ann Surg 229:755-764
13. Ho AD, Feurle G, Gless KH, Brandeis WE (1978) Normotensive familial phaeochromocytoma with predominant noradrenaline secretion. Br Med J 1:81-82
14. Knüttgen D, Wappler F (2008) Anästhesie bei Phäochromozytom Besonderheiten, mögliche Komplikationen und medikamentöse Strategien. Anasthesiol Intensivmed Notfallmed Schmerzther 43:20-27
15. Kopetschke R, Slisko M, Kilisli A et al (2009) Frequent incidental discovery of phaeochromocytoma: data from a German cohort of 201 phaeochromocytoma. Eur J Endocrinol 161:355-361
16. Lehnert H, Hahn K, Dralle H (2002) Benignes und malignes Phäochromozytom. Internist 43:196-209
17. Lenders JW, Eisenhofer G, Mannelli M, Pacak K (2005) Pheochromocytoma. Lancet 36:665-675
18. Lentschener C, Gaujoux S, Tesniere A, Dousset B (2011) Point of controversy: perioperative care of patients undergoing pheochromocytoma removal-time for a reappraisal Eur J Endocrinol 165:365-373
19. Lund-Johansen P, Kirby RS (2003) Effect of doxazosin GITS on blood pressure in hypertensive and normotensive patients: a review of hypertension and BPH studies. Blood Press 1:5-13
20. Mannelli M, Ianni L, Cilotti A, Conti A (1999) Pheochromocytoma in Italy: a multicentric retrospective study. Eur J Endocrinol 141:619-624
21. Myklejord DJ (2004) Undiagnosed pheochromocytoma: the anesthesiologist nightmare. Clin Med Res 2:59-62
22. Pacak K (1992) Preoperative management of the pheochromocytoma patient. J Clin Endocrinol Metab 92:4069-4079
23. Prys-Roberts C, Farndon JR (2002) Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma. World J Surg 26:1037-1042
24. Shao Y, Chen R, Shen ZJ et al (2011) Preoperative alpha blockade for normotensive pheochromocytoma: is it necessary J Hypertens 29:2429-2432
25. Shen SJ, Cheng HM, Chiu AW et al (2003) Clinically silent pheochromocytoma in adrenal incidentaloma: a case report and review of the literature. J Intern Med Taiwan 14:248-254
26. Song G, Joe BN, Yeh BM et al (2011) Risk of catecholamine crisis in patients undergoing resection of unsuspected pheochromocytoma. Int Braz J Urol 37:35-40
27. Weingarten TN, Cata JP, O'Hara JF et al (2010) Comparison of two preoperative medical management strategies for laparoscopic resection of pheochromocytoma. Urology 76:508-511
28. Zelinka T, Widimský J, Weisserová J (2001) Diminished circadian blood pressure rhythm in patients with asymptomatic normotensive pheochromocytoma. Physiol Res 50:631-631
29. Zhu Y, He HC, Su TW et al (2010) Selective 1-adrenoceptor antagonist (controlled release tablets) in preoperative management of pheochromocytoma. Endocr 38:254-259